IGBP1 is a novel biomarker in lupus nephritis (LN) patients, its expression level is increased in the plasma and urine of patients with LN compared with systemic lupus erythematosus (SLE) patients without nephritis and healthy controls [54, 55]. Here, IGBP1 is linked to systemic lupus erythematosus.